# Supreme Pharmaceuticals Inc.: Form D filings

Supreme Pharmaceuticals Inc., a pharmaceuticals company in Toronto, Ontario, Canada, filed 6 Form D notices with the SEC between 2014 and 2017. The latest, on March 17, 2017, reports $369,667 sold of a $369,667 offering to 1 investor.

Find out what Supreme Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Supreme%20Pharmaceuticals%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Supreme%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsupreme-pharmaceuticals-inc-1622240)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Supreme%20Pharmaceuticals%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Supreme%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsupreme-pharmaceuticals-inc-1622240)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 202 - 20 De Boers Drive, Toronto, Ontario, Canada, M3J 0
- Phone: (647) 525-5463
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: British Columbia, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1622240

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 17, 2017 | New notice | $369,667 | $369,667 | $0 | 1 | Dec 13, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1622240/000162224017000001/0001622240-17-000001-index.htm) |
| May 8, 2015 | New notice | $1,212,649 | $1,212,649 | $0 | 27 | Apr 23, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1622240/000162224015000002/0001622240-15-000002-index.htm) |
| Feb 3, 2015 | New notice | $116,985 | $116,985 | $0 | 3 | Jan 23, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1622240/000162224015000001/0001622240-15-000001-index.htm) |
| Nov 20, 2014 | New notice | $149,117 | $149,117 | $0 | 5 | Sep 19, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1622240/000162224014000003/0001622240-14-000003-index.htm) |
| Nov 10, 2014 | New notice | $538,049 | $538,049 | $0 | 12 | Nov 5, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1622240/000162224014000002/0001622240-14-000002-index.htm) |
| Oct 20, 2014 | New notice | $525,800 | $525,800 | $0 | 7 | Sep 19, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1622240/000162224014000001/0001622240-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Scott Walters | Director |  |
| Chuck Rifici | Director |  |
| Navdeep Dhaliwal | Executive Officer, Director |  |
| John Fowler | Executive Officer, Director |  |
| Michael La Brier | Director |  |

[Every Form D from the week of Mar 13, 2017](https://specstream.ai/data/form-d/week/2017-03-13) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Supreme Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).